| Dr Chris Robert Hughes, PHD | |
|
110 N Meadowbrook Dr, Alpine, UT 84004-1775 | |
| (801) 995-5180 | |
| Not Available |
| Full Name | Dr Chris Robert Hughes |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 110 N Meadowbrook Dr, Alpine, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083846810 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chris Robert Hughes, PHD 110 N Meadowbrook Dr, Alpine, UT 84004-1775 Ph: (801) 995-5180 | Dr Chris Robert Hughes, PHD 110 N Meadowbrook Dr, Alpine, UT 84004-1775 Ph: (801) 995-5180 |
News Archive
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.
CSL Behring today presented results of a pre-clinical study that not only demonstrates the feasibility of genetically fusing factor VIIa to human albumin, but that this therapeutic protein with a prolonged half-life can lead to a longer biologic effect.
Verenium Corporation, a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it has been awarded an additional $4.9 million from the U.S. Department of Energy (DOE) to fund ongoing activities at its demonstration-scale facility in Jennings, Louisiana.
Pomalidomide (trade name: Imnovid) has been approved since 2013 for the treatment of multiple myeloma that has returned and is difficult to treat. The drug is an option for adults who have received two or more prior treatment regimens, including treatment with the drugs lenalidomide and bortezomib, and in whom the last treatment had no sufficient effect.
› Verified 3 days ago
Dr. Chris Donald Anderson, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 745 W 600 N, Alpine, UT 84004 Phone: 801-400-1228 |